Retraction: Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK
- 1Proteomics Group, Institute for Clinical Chemistry/UMG-Laboratories, University Medical Centre, Goettingen, Germany
- 2Department of Biotechnology and Genetic Engineering, Kohat University of Science and Technology, Kohat, Pakistan
- 3Department of Microbiology, Kohat University of Science and Technology, Kohat, Pakistan
Citation: Khan N, Pantakani DVK, Binder L, Qasim M and Asif AR (2015) Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK. Front. Physiol. 6:381. doi: 10.3389/fphys.2015.00381
Received: 20 September 2015; Accepted: 24 November 2015;
Published: 22 December 2015; Retracted: 19 September 2017.
Edited by:
Alexis E. Traynor-Kaplan, ISM Therapeutics, USAReviewed by:
Georg Singer, Medical University of Graz, AustriaR. John MacLeod, Queen's University, Canada